| cis-eQTL |
cohort |
8 |
6 |
FDR-matched cis-eQTLs, cis eQTL, cis expression quantitative trait locus, cis-eQTL, cis-eQTL signals, cis-eQTL subsignals, cis-eQTLs, cis‑eQTL, single-tissue cis-eQTL |
| citalopram |
drug |
5 |
3 |
|
| class 1 |
cohort |
4 |
2 |
class 1, latent class 1 |
| class 2 |
cohort |
4 |
3 |
class 2, class 2 members, higher severity class, latent class 2 |
| class 3 |
cohort |
3 |
2 |
class 3, class 3 members, latent class 3, most severe class |
| class 4 |
cohort |
2 |
1 |
|
| cleft palate |
phenotype |
3 |
1 |
|
| clinical cohort |
cohort |
7 |
2 |
clinical, clinical cohort, clinical sample |
| clinical phenotypes |
phenotype |
6 |
5 |
broad clinical phenotype |
| clinical population |
cohort |
5 |
2 |
clinical populations |
| clinical samples |
cohort |
8 |
2 |
clinical, clinical samples |
| clinical trial |
cohort |
3 |
1 |
|
| clinical trials |
cohort |
6 |
3 |
underpowered early-phase clinical trials |
| clinicians |
cohort |
2 |
1 |
|
| CLM |
gene |
3 |
2 |
Colombian, Colombian in Medellin, Colombia |
| CLOCK |
gene |
5 |
3 |
Clock protein, circadian locomotor output cycles kaput |
| clonazepam |
drug |
2 |
1 |
|
| Clontech |
drug |
3 |
— |
|
| clozapine |
drug |
9 |
6 |
clozapine, clozapine (5.2 mg/kg/d) |
| CLTCL1 |
gene |
3 |
3 |
Cltc, clathrin heavy chain-like 1 |
